Chinook Therapeutics, Inc.
Pharmaceutical company · Seattle, Washington, United States
Chinook Therapeutics, Inc. is a pharmaceutical company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2011. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $684,763 in total, most recently in 2014. It has reported private securities offerings to the US SEC, most recently $51 million sold in a notice filed in 2015.
Chinook Therapeutics at a glance
What does Chinook Therapeutics do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $684,763 in total (2010 to 2014).
Private fundraising reported to the SEC
9 Form D notices; the most recent reported $51.4 million sold (2015).
Frequently asked questions about Chinook Therapeutics
Where is Chinook Therapeutics headquartered?
Chinook Therapeutics, Inc. is headquartered in Seattle, Washington, United States.
What does Chinook Therapeutics do?
Chinook Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Chinook Therapeutics founded?
The earliest incorporation on record for Chinook Therapeutics, Inc. is in 2011, according to public company registers.
Similar companies
- Omeros CorpSeattle, Washington, United States
- Cti Biopharma CorpSeattle, Washington, United States
- Perspective Therapeutics, Inc.Seattle, Washington, United States
- Aptevo Therapeutics Inc.Seattle, Washington, United States
- IPI Legacy Liquidation CoSeattle, Washington, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.